Sangmee Ahn Jo

Title: Sangmee Ahn Jo: Inventor in Neurodegenerative Disease Research.

Introduction

Sangmee Ahn Jo is an inventor associated with Goyang, South Korea. His patent work concerns a protein intended to inhibit beta-amyloid aggregation, a process relevant to research into neurodegenerative disorders such as Alzheimer’s disease.

Latest Patents

The available information identifies one patent associated with Jo: “Protein Inhibiting Aggregation of Beta Amyloid Peptide.” The invention describes a novel protein that inhibits beta-amyloid aggregation, the gene encoding that protein, and a strain that produces it. It also describes a potential therapeutic agent containing the protein as an active ingredient for preventing or treating neurodegenerative disorders. The supplied information does not establish when this patent was granted or whether it is his most recent patent. Jo is credited with 1 patent in the data provided.

Career Highlights

Jo’s listed invention focuses on a biological approach to limiting beta-amyloid aggregation. The patent describes potential therapeutic applications, including research related to Alzheimer’s disease. The listed assignee is the United States of America, as Represented by the Secretary, Department of Health and Human Services.

Collaborations

The supplied information names Inho Jo and Ho Jeong Kwon as Jo’s coworkers. It does not specify their individual roles in the patent or the research.

Conclusion

Sangmee Ahn Jo’s documented patent work centers on a protein-based approach to inhibiting beta-amyloid aggregation, with potential relevance to therapies for neurodegenerative disorders.